Enago Partners with Bioscientifica

By , in PR PR Health on .
November 17, 2017 – London: Under this new collaboration, Enago’s high-quality English editing and publication support services will be offered to Bioscientifica’s global research community at a reduced price.

The aim of the partnership is to improve the quality of biomedical research papers submitted by authors, helping them to meet the stringent submission standards of international, high-impact journals. Those who access Enago’s services can choose from two levels of editing: Copy Editing and Substantive Editing.

Enago’s expert editing team of qualified editing professionals and published authors specialised in over 250+ biomedical subject areas so researchers can submit their papers with the confidence that the content will be handled sensitively and professionally. It’s a partnership that offers mutual benefits to all involved.

“Our affiliation with Bioscientifica presents a unique opportunity,” said Rajiv Shirke, VP Global Operations, Enago. “We are delighted to partner with such an established name and to offer our expertise in scientific editing and publishing to researchers specialising in this important field. This collaboration will enable us to help more authors improve the quality of their work and achieve their publication goals”.

Also speaking about the new partnership, Bioscientifica is confident these services will not only benefit the author but also the industry. “Our focus has always been on strengthening research and knowledge in the field of biomedicine to advance science and health,” said Kathryn Spiller, Head of Publishing at Bioscientifica. “By working with Enago to enable access to high-quality editing services at reduced cost, we’re ensuring the focus is on clear communication of the scientific and medical research that our authors are presenting for publication.”.

Authors in Bioscientifica’s research community will be able to access Enago’s services and take advantage of the 20% discount via a co-branded web portal.

For more information visit – enago.com/bioscientifica

About Enago
A trusted name in the global research community, Enago specialises in providing scientific and academic editing and publishing services to research authors. Since 2005, they helped researchers in over 125 countries improve the quality of their written work and achieve publication success. With offices in Tokyo, Seoul, Beijing, Shanghai, Istanbul, and New York, they operate internationally with regional teams delivering local support. Enago is a preferred partner for leading publishers, societies and universities worldwide.

To find out more visit enago.com

About Bioscientifica
For 20 years, Bioscientifica have been collaborating with learned societies worldwide to provide high-quality publishing, events and association management to the biomedical and bioscience communities.

Bioscientifica exists to support biomedicine. Through their expertise in publishing, events and association management they strengthen biomedical communities to advance science and health.

Bioscientifica is owned by the Society for Endocrinology, and all their profits are redistributed back to biomedicine.

To find out more visit bioscientifica.com

###

The following two tabs change content below.
Brad Bennett

Brad Bennett

Brad grew up in a small town in northern Iowa. He studied chemistry in college, graduated, and married his wife one month later. They were then blessed with two baby boys within the first four years of marriage. Having babies gave their family a desire to return to the old paths – to nourish their family with traditional, homegrown foods; rid their home of toxic chemicals and petroleum products; and give their boys a chance to know a simple, sustainable way of life. They are currently building a homestead from scratch on two little acres in central Texas. There’s a lot to be done to become somewhat self-sufficient, but they are debt-free and get to spend their days living this simple, good life together with their five young children.
%d bloggers like this: